Early diagnosis of cardiac allograft vasculopathy (CAV) is of utmost importance as it allows alterations to optimal immunosuppression and risk factor modification prolonging graft survival and reducing morbidity and mortality. In most transplant centers<unk><unk>  is currently used to screen and diagnose transplant associated<unk>  artery disease.
Cardiac allograft vasculopathy coronary angiography
Cardiac allograft vasculopathy intravascular ultrasound
Cardiac allograft vasculopathy optical coherence tomography
Cardiac allograft vasculopathy screening
Granulomatosis with polyangiitis screening
Cardiac amyloidosis electrocardiogram
Cardiac amyloidosis CT scan
Cardiac amyloidosis cardiac biopsy